| 1 |
Li Q, Zhou Z, Chen Y, Yu J, Zhang H, Meng Y, Zhu M, Li N, Zhou J, Liu F, Fang X, Li J, Wang T, Lu J, Zhang T, Xu J, Shao C, Bian Y. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 2023. [PMID: 36964775 DOI: 10.1007/s00261-023-03801-8] [Reference Citation Analysis]
|
| 2 |
Kovac JD, Djikic-rom A, Bogdanovic A, Jankovic A, Grubor N, Djuricic G, Dugalic V. The Role of MRI in the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas and Its Mimickers: A Case-Based Review with Emphasis on Differential Diagnosis. Diagnostics 2023;13:1074. [DOI: 10.3390/diagnostics13061074] [Reference Citation Analysis]
|
| 3 |
Burns L, Naimi B, Ronan M, Xu H, Weber HC. Report of a Novel Molecular Profile in Malignant Insulinoma. J Clin Med 2023;12. [PMID: 36835815 DOI: 10.3390/jcm12041280] [Reference Citation Analysis]
|
| 4 |
Yuan J, Wang Y, Hu X, Shi S, Zhang N, Wang L, Deng W, Feng ST, Peng Z, Luo Y. Use of dual-layer spectral detector computed tomography in the diagnosis of pancreatic neuroendocrine neoplasms. Eur J Radiol 2023;159:110660. [PMID: 36577182 DOI: 10.1016/j.ejrad.2022.110660] [Reference Citation Analysis]
|
| 5 |
Schwartz FR, Samei E, Marin D. Exploiting the Potential of Photon-Counting CT in Abdominal Imaging. Invest Radiol 2023. [PMID: 36728045 DOI: 10.1097/RLI.0000000000000949] [Reference Citation Analysis]
|
| 6 |
Müller-debus C, Wellner U, Keck T. Sporadische duodenale neuroendokrine Neoplasien. Springer Reference Medizin 2023. [DOI: 10.1007/978-3-662-63317-5_41] [Reference Citation Analysis]
|
| 7 |
Koffas A, Giakoustidis A, Papaefthymiou A, Bangeas P, Giakoustidis D, Papadopoulos VN, Toumpanakis C. Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Front Surg 2023;10:1064145. [PMID: 36950054 DOI: 10.3389/fsurg.2023.1064145] [Reference Citation Analysis]
|
| 8 |
Vladova PT. Classification of Gastroenteropancreatic Neuroendocrine Tumors. Journal of Biomedical and Clinical Research 2022;15:123-129. [DOI: 10.2478/jbcr-2022-0017] [Reference Citation Analysis]
|
| 9 |
Ma H, Jiang K, Hong Y, Lei Y, Fan Y, Jiang W, Zhao L, Liu J, Yao W, Xu J, He M, Wei M. Screening of an annexin-A2-targeted heptapeptide for pancreatic adenocarcinoma localization. Mol Oncol 2022. [PMID: 36453020 DOI: 10.1002/1878-0261.13352] [Reference Citation Analysis]
|
| 10 |
Chiapponi C, Bruns CJ. Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas. best practice onkologie 2022. [DOI: 10.1007/s11654-022-00451-y] [Reference Citation Analysis]
|
| 11 |
La Salvia A, Persano I, Parlagreco E, Audisio A, Cani M, Brizzi MP. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon. Med Oncol 2022;39:168. [PMID: 35972607 DOI: 10.1007/s12032-022-01764-2] [Reference Citation Analysis]
|
| 12 |
Chiapponi C, Bruns CJ. Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas. Chirurgie 2022;93:731-738. [DOI: 10.1007/s00104-022-01645-4] [Reference Citation Analysis]
|
| 13 |
Pan Q, Yang W, Zhang Z, Shao Z. Rare Bone Metastasis of Neuroendocrine Tumors of Unknown Origin: A Case Report and Literature Review. Orthop Surg 2022. [PMID: 35856167 DOI: 10.1111/os.13384] [Reference Citation Analysis]
|
| 14 |
Ilhan H, Schnitzer ML, Rübenthaler J. Neuroendokrine Tumoren – von der morphologischen zur funktionellen Bildgebung. Radiopraxis 2022;15:E35-E47. [DOI: 10.1055/a-1714-2040] [Reference Citation Analysis]
|
| 15 |
Gherghe M, Lazăr AM, Stanciu AE, Mutuleanu MD, Sterea MC, Petroiu C, Galeș LN. The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? Cancers (Basel) 2022;14:2725. [PMID: 35681704 DOI: 10.3390/cancers14112725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Lin ZQ, Li X, Yang Y, Wang Y, Zhang XY, Zhang XX, Guo J. Nonfunctional pancreatic neuroendocrine tumours misdiagnosed as autoimmune pancreatitis: A case report and review of literature. World J Clin Cases 2022; 10(15): 4886-4894 [DOI: 10.12998/wjcc.v10.i15.4886] [Reference Citation Analysis]
|
| 17 |
Zhang Z, Wang F, Li Z, Ye Z, Zhuo Q, Xu W, Liu W, Liu M, Fan G, Qin Y, Zhang Y, Chen X, Yu X, Xu X, Ji S. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors. BMC Surg 2022;22:160. [PMID: 35538535 DOI: 10.1186/s12893-022-01595-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Mroueh N, Cao J, Kambadakone A. Dual-Energy CT in the Pancreas. Journal of Gastrointestinal and Abdominal Radiology. [DOI: 10.1055/s-0042-1744494] [Reference Citation Analysis]
|
| 19 |
Muros MA, Aroui T, Rivas-navas D, Fernandez-fernadez J. Integration of molecular imaging in the personalized approach to neuroendocrine tumors. Q J Nucl Med Mol Imaging 2022;66. [DOI: 10.23736/s1824-4785.22.03431-8] [Reference Citation Analysis]
|
| 20 |
Duan S, Sontz RA, Merchant JL, Sawyer TW. Measuring variations in optical imaging markers in a glial cell-directed mouse model of human MEN1 syndrome. Label-free Biomedical Imaging and Sensing (LBIS) 2022 2022. [DOI: 10.1117/12.2608797] [Reference Citation Analysis]
|
| 21 |
Ilhan H, Schnitzer M, Rübenthaler J. Neuroendokrine Tumoren – von der morphologischen zur funktionellen Bildgebung. Onkologie up2date 2022;04:93-106. [DOI: 10.1055/a-1712-0674] [Reference Citation Analysis]
|
| 22 |
Lee L, Ramos-Alvarez I, Jensen RT. Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies. Cancers (Basel) 2022;14:1250. [PMID: 35267558 DOI: 10.3390/cancers14051250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Kaewput C, Vinjamuri S. Role of Combined 68Ga DOTA-Peptides and 18F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms. Diagnostics 2022;12:280. [DOI: 10.3390/diagnostics12020280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Havasi A, Sur D, Cainap SS, Lungulescu CV, Gavrilas LI, Cainap C, Vlad C, Balacescu O. Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers. Int J Mol Sci 2022;23. [PMID: 35163032 DOI: 10.3390/ijms23031109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Müller-debus C, Wellner U, Keck T. Sporadische duodenale neuroendokrine Neoplasien. Springer Reference Medizin 2022. [DOI: 10.1007/978-3-662-61724-3_41-1] [Reference Citation Analysis]
|
| 26 |
Borri F, Bonfiglio R, Mandarano M. Pathology of Pancreatic Neuroendocrine Tumors. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_37] [Reference Citation Analysis]
|
| 27 |
German J, Burke LMB, Rowell JV. Clinical, Laboratory, and Radiological Diagnosis of Pancreatic Islet Cell Tumors. Diagnosis and Management of Endocrine Disorders in Interventional Radiology 2022. [DOI: 10.1007/978-3-030-87189-5_5] [Reference Citation Analysis]
|
| 28 |
Hou J, Yang Y, Chen N, Chen D, Hu S. Prognostic Value of Volume-Based Parameters Measured by SSTR PET/CT in Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:771912. [PMID: 34901087 DOI: 10.3389/fmed.2021.771912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Halperin R, Ahron-Hananel G, Badarna M, Greidinger D, Uri I, Percik R, Tirosh A. Plasma Hemoglobin and Red Blood Cell Mass Levels as Dynamic Prognostic Markers for Progression and Survival in Pancreatic Neuroendocrine Tumors. Horm Metab Res 2021;53:810-7. [PMID: 34891211 DOI: 10.1055/a-1672-4653] [Reference Citation Analysis]
|
| 30 |
Del Olmo-Garcia MI, Prado-Wohlwend S, Andres A, Soriano JM, Bello P, Merino-Torres JF. Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms. Biomedicines 2021;9:1810. [PMID: 34944626 DOI: 10.3390/biomedicines9121810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Ilhan H, Schnitzer ML, Rübenthaler J. Neuroendokrine Tumoren – von der morphologischen zur funktionellen Bildgebung. Der Nuklearmediziner 2021;44:313-325. [DOI: 10.1055/a-1652-4899] [Reference Citation Analysis]
|
| 32 |
Walczak R, Kawalilak L, Griffin L. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020). J Small Anim Pract 2021. [PMID: 34811734 DOI: 10.1111/jsap.13446] [Reference Citation Analysis]
|
| 33 |
Yang Y, Shi J, Zhu J. Diagnostic performance of noninvasive imaging modalities for localization of insulinoma: A meta-analysis. Eur J Radiol 2021;145:110016. [PMID: 34763145 DOI: 10.1016/j.ejrad.2021.110016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 34 |
Lysanyuk MV, Romashchenko PN, Maistrenko NA. Current aspects of diagnosis and treatment of patients with neuroendocrine tumors. Bulletin of the Russian Military Medical Academy 2021;23:83-92. [DOI: 10.17816/brmma72345] [Reference Citation Analysis]
|
| 35 |
Segaran N, Devine C, Wang M, Ganeshan D. Current update on imaging for pancreatic neuroendocrine neoplasms. World J Clin Oncol 2021; 12(10): 897-911 [PMID: 34733612 DOI: 10.5306/wjco.v12.i10.897] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Chen X, Hao F, Gui Y, Zhang J, Tan L, Xiao M, Zhang Q, Meng H, Li J, Jiang Y, Lv K. Enhancement patterns in the venous phase of contrast-enhanced ultrasounds: diagnostic value for patients with solid pancreatic lesions. Quant Imaging Med Surg 2021;11:4321-33. [PMID: 34603987 DOI: 10.21037/qims-20-1248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 37 |
Pirasteh A, Lovrec P, Bodei L. Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities. Rev Endocr Metab Disord 2021;22:539-52. [PMID: 33783695 DOI: 10.1007/s11154-021-09631-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 38 |
Partouche E, Yeh R, Eche T, Rozenblum L, Carrere N, Guimbaud R, Dierickx LO, Rousseau H, Dercle L, Mokrane FZ. Updated Trends in Imaging Practices for Pancreatic Neuroendocrine Tumors (PNETs): A Systematic Review and Meta-Analysis to Pave the Way for Standardization in the New Era of Big Data and Artificial Intelligence. Front Oncol 2021;11:628408. [PMID: 34336643 DOI: 10.3389/fonc.2021.628408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Półtorak-Szymczak G, Budlewski T, Furmanek MI, Wierzba W, Sklinda K, Walecki J, Mruk B. Radiological Imaging of Gastro-Entero-Pancreatic Neuroendocrine Tumors. The Review of Current Literature Emphasizing the Diagnostic Value of Chosen Imaging Methods. Front Oncol 2021;11:670233. [PMID: 34211845 DOI: 10.3389/fonc.2021.670233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 40 |
Hu Y, Ye Z, Wang F, Qin Y, Xu X, Yu X, Ji S. Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy. Front Endocrinol (Lausanne) 2021;12:679000. [PMID: 34093445 DOI: 10.3389/fendo.2021.679000] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 41 |
Noguchi T, Ryozawa S, Mizuide M, Tanisaka Y, Fujita A, Ogawa T, Suzuki M, Katsuda H, Nagata K, Kawasaki T, Aikawa M, Okamoto K. Pancreatic Hamartoma Difficult to Diagnose Preoperatively. Intern Med 2021;60:2055-9. [PMID: 33518562 DOI: 10.2169/internalmedicine.5982-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 42 |
Borri F, Bonfiglio R, Mandarano M. Pathology of Pancreatic Neuroendocrine Tumors. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_37-1] [Reference Citation Analysis]
|
| 43 |
Waguespack SG, Fishbein L. Pheochromocytoma/Paraganglioma, Medullary Thyroid Carcinoma, and Hereditary Endocrine Neoplasia Syndromes. Sperling Pediatric Endocrinology 2021. [DOI: 10.1016/b978-0-323-62520-3.00015-4] [Reference Citation Analysis]
|
| 44 |
Ito T, Jensen RT. Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes. Expert Opin Pharmacother 2021;22:685-93. [PMID: 33131345 DOI: 10.1080/14656566.2020.1845651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Khanna L, Prasad SR, Sunnapwar A, Kondapaneni S, Dasyam A, Tammisetti VS, Salman U, Nazarullah A, Katabathina VS. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification. Radiographics 2020;40:1240-62. [PMID: 32795239 DOI: 10.1148/rg.2020200025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 46 |
Del Olmo-García MI, Muros MA, López-de-la-Torre M, Agudelo M, Bello P, Soriano JM, Merino-Torres JF. Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal. J Clin Med 2020;9:E2203. [PMID: 32664679 DOI: 10.3390/jcm9072203] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 47 |
Zhang H, Shang D. Nonfunctional Pancreatic Neuroendocrine Carcinoma With Isolated Retroperitoneal Metastasis: A Case Report and Literature Review. Pancreas 2020;49:e29-31. [PMID: 32101939 DOI: 10.1097/MPA.0000000000001468] [Reference Citation Analysis]
|
| 48 |
Velikyan I. (Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer. Pharmaceuticals (Basel) 2020;13:E39. [PMID: 32151049 DOI: 10.3390/ph13030039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 49 |
Pettersson O, Fröss-Baron K, Crona J, Sundin A. Tumor Contrast-Enhancement for Monitoring of PRRT 177Lu-DOTATATE in Pancreatic Neuroendocrine Tumor Patients. Front Oncol 2020;10:193. [PMID: 32154181 DOI: 10.3389/fonc.2020.00193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 50 |
Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029-1050. [PMID: 31738624 DOI: 10.1080/14737140.2019.1693893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
|
